Similar companies
| Company | Transaction Value | |
|---|---|---|
 |
OcugenOCGN |
$78,000 |
 |
AmarinAMRN |
$520,000 |
 |
Gilead SciencesGILD |
-$2B |
 |
Anavex Life SciencesAVXL |
-$6.3M |
 |
AmgenAMGN |
-$109M |
Insider Transactions
| Name | Transaction Date | Sold / Bought | Shares | Price | Value |
|---|---|---|---|---|---|
| Iwicki Mark T | Oct 23, 2025 | Sell | 154,894 | $0.81 | $130,000 |
| Reumuth Mary | Oct 23, 2025 | Sell | 967 | $0.82 | $790 |
| Kharabi Darius | Oct 22, 2025 | Sell | 20,806 | $0.83 | $17,000 |
| Reumuth Mary | Oct 22, 2025 | Sell | 32,230 | $0.83 | $27,000 |
| Bazemore Todd | Oct 22, 2025 | Sell | 47,768 | $0.83 | $40,000 |
| Brazzell Romulus K | Oct 22, 2025 | Sell | 46,748 | $0.83 | $39,000 |
| BAKER JULIAN | Oct 1, 2025 | Sell | 462,967 | $1.3838 | $640,000 |
| BAKER JULIAN | Oct 1, 2025 | Sell | 50,640 | $1.3838 | $70,000 |
| BAKER JULIAN | Sep 30, 2025 | Sell | 195,425 | $1.5959 | $310,000 |
| BAKER JULIAN | Sep 30, 2025 | Sell | 21,376 | $1.5959 | $34,000 |
| Iwicki Mark T | Jun 24, 2025 | Sell | 13,227 | $4.01 | $53,000 |
| Kharabi Darius | Jun 24, 2025 | Sell | 4,511 | $4.01 | $18,000 |
| Reumuth Mary | Jun 24, 2025 | Sell | 3,631 | $4.01 | $15,000 |
| Bazemore Todd | Jun 24, 2025 | Sell | 4,058 | $4.01 | $16,000 |
| Brazzell Romulus K | Jun 24, 2025 | Sell | 5,251 | $4.01 | $21,000 |
| Iwicki Mark T | Jun 3, 2025 | Sell | 10,866 | $3.74 | $41,000 |
| Iwicki Mark T | Jun 3, 2025 | Sell | 10,866 | $3.74 | $41,000 |
| Reumuth Mary | Jun 3, 2025 | Sell | 2,850 | $3.74 | $11,000 |
| Bazemore Todd | Jun 3, 2025 | Sell | 3,390 | $3.74 | $13,000 |
| Brazzell Romulus K | Jun 3, 2025 | Sell | 3,687 | $3.74 | $14,000 |
| Kharabi Darius | Jun 3, 2025 | Sell | 730 | $3.74 | $2,700 |
| Kharabi Darius | Jan 6, 2025 | Sell | 2,021 | $7.63 | $15,000 |
| Bazemore Todd | Jan 6, 2025 | Sell | 1,993 | $7.63 | $15,000 |
| Brazzell Romulus K | Jan 6, 2025 | Sell | 2,446 | $7.63 | $19,000 |
| Iwicki Mark T | Jan 6, 2025 | Sell | 5,779 | $7.63 | $44,000 |
| Reumuth Mary | Jan 6, 2025 | Sell | 1,706 | $7.63 | $13,000 |
| BAKER JULIAN | Dec 30, 2024 | Buy | 279,939 | $6.44 | $1.8M |
| BAKER JULIAN | Dec 30, 2024 | Buy | 30,620 | $6.44 | $200,000 |
| Iwicki Mark T | Jun 26, 2024 | Sell | 15,168 | $4.75 | $72,000 |
| Bazemore Todd | Jun 26, 2024 | Sell | 4,653 | $4.75 | $22,000 |
| Kharabi Darius | Jun 26, 2024 | Sell | 5,158 | $4.75 | $25,000 |
| Reumuth Mary | Jun 26, 2024 | Sell | 4,163 | $4.75 | $20,000 |
| Brazzell Romulus K | Jun 26, 2024 | Sell | 5,489 | $4.75 | $26,000 |
| Bazemore Todd | May 31, 2024 | Sell | 2,093 | $6.09 | $13,000 |
| Reumuth Mary | May 31, 2024 | Sell | 1,786 | $6.09 | $11,000 |
| Brazzell Romulus K | May 31, 2024 | Sell | 2,002 | $6.09 | $12,000 |
| Iwicki Mark T | May 31, 2024 | Sell | 7,392 | $6.09 | $45,000 |
| Kharabi Darius | May 31, 2024 | Sell | 231 | $6.09 | $1,400 |
FAQ - Insider Transactions
The most recent insider transaction for Kala Pharmaceuticals was conducted by Iwicki Mark T, who sold 154,894 shares on October 23, 2025 at a price of $0.81 per share.
BAKER JULIAN has bought the most KALA stock in the last 2 years, with a total value of $2M.
BAKER JULIAN has sold the most KALA stock in the last 2 years, with a total value of $1.1M.
According to our estimates, the total value of insider transactions for Kala Pharmaceuticals in the last 2 years is positive, amounting to $97,000. This indicates that insiders have predominantly bought shares, showcasing their confidence in the company's future prospects.
Over the last 2 years, insider transactions for Kala Pharmaceuticals have largely consisted of selling shares, which could suggest various personal or financial motivations among insiders. The higher number of sales might require investors to investigate further, considering insiders might have insights or reasons not immediately apparent to the public.
Monitoring insider trading activity is important because it provides insights into the confidence levels of a company's insiders, such as executives and directors, regarding the company's future prospects. Insider buying can signal optimism, suggesting the stock may be undervalued, while insider selling might raise questions about the stock's upcoming performance. However, it's essential to consider that sales can also occur for personal financial reasons. Insider trading activity is a valuable indicator that, when combined with other data, can help inform investment decisions.
